Volitionrx limitedVNRX.US Overview

US StockHealthcare

(No presentation for VNRX)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

VNRX Overall Performance

VNRX AI Analysis & Strategy

VNRX Recent Performance

-1.87%

Volitionrx limited

0.81%

Avg of Sector

-1.14%

S&P500

VNRX PowerScanner

VNRX Key Information

VNRX Valuation Metrics

VNRX Earnings Table

VNRX Profile

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.